Back to company

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN: Financial statements 2024

CVR: 19040089

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN (CVR 19040089) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 2,351,812 and a net result of DKK 1,569,542 compared with DKK 1,366,095 the year before. That is an increase of 10.5% compared with the year before. The profit margin was 66.7%. Equity amounted to DKK 14,950,740. The solvency ratio was 96%.

Revenue
2,351,812 kr.
Gross Profit
613,400 kr.
Profit/Loss
1,569,542 kr.
Equity
14,950,740 kr.
Total Assets
15,565,917 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20242.4 mio.613 t.1.6 mio.15 mio.0
20232.1 mio.516 t.1.4 mio.14.4 mio.0
20222 mio.247 t.-936 t.13.7 mio.0
20211.8 mio.495 t.1.6 mio.15.9 mio.-
20202 mio.586 t.951 t.15.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN: The 2023 annual report is outJun 25, 2024

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN has published its annual report for 2023. Revenue came to DKK 2,128,683, and the net result was DKK 1,366,095.

Karin Ingrid Margreta Löwnhagen joins the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENMar 1, 2024

As of March 1, 2024, Karin Ingrid Margreta Löwnhagen has joined the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

Christian Aage Wamberg joins the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENFeb 1, 2024

As of February 1, 2024, Christian Aage Wamberg has joined the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

Svein Arne Monsen joins the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENFeb 1, 2024

As of February 1, 2024, Svein Arne Monsen has joined the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

Kari Hreinsson joins the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENFeb 1, 2024

As of February 1, 2024, Kari Hreinsson has joined the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

Timo Ilari Kaakinen joins the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENFeb 1, 2024

As of February 1, 2024, Timo Ilari Kaakinen has joined the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

Klaus Olkkola leaves the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENFeb 1, 2024

As of February 1, 2024, Klaus Olkkola has left the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

Katrin Thormar leaves the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENFeb 1, 2024

As of February 1, 2024, Katrin Thormar has left the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

Jon Henrik Laake leaves the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENFeb 1, 2024

As of February 1, 2024, Jon Henrik Laake has left the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

Maja Ewert leaves the board of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDENFeb 1, 2024

As of February 1, 2024, Maja Ewert has left the board of directors of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN.

About ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN is a Danish company of the type Erhvervsdrivende fond based in København V, founded in 1999. The company is registered under the industry Andre udgiveraktiviteter, undtagen udgivelse af software. The management consists of Sören Erik Pischke. In 2024, the company reported revenue of DKK 2,351,812 and a net result of DKK 1,569,542 compared with DKK 1,366,095 the year before. Equity amounted to DKK 14,950,740.